Ingevity (NGVT) is Initiated by Buckingham Research to Neutral

Ingevity (NGVT) was Initiated by Buckingham Research to “Neutral”. Buckingham Research advised their investors in a research report released on Sep 23, 2016.

Many Wall Street Analysts have commented on Ingevity. KeyBanc Capital Mkts Initiated Ingevity on Jul 7, 2016 to “Overweight”, Price Target of the shares are set at $43.


Leave a Reply

Ingevity - Is it time to Sell?

Top Brokerage Firms are advising their investors on Ingevity. Subscribe to MoneyFlowIndex.Org Pre-Market Alerts, You will be the first to know the street buzz.